Active Shortage Capsule Anti-Infective
Rifampin Capsule · #17 of 35 active shortages by FDA posting duration
Brand: RIFAMPIN
FDA lists Rifampin Capsule as Active Shortage (Epic Pharma, LLC).
Availability on file: Available
Rifampin Capsule: Active Shortage
Available 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rifampin Capsule
- Manufacturer
- Epic Pharma, LLC
- Dosage Form
- Capsule
- Presentation
- Rifampin, Capsule, 300 mg (NDC 42806-799-60)
- Package NDC
- 42806-799-60
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 22, 2021
- Last Updated
- Mar 5, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
rifampin
Side effects, interactions, warnings & more
Nearby, Other Rifampin Shortage Records
Rifampin Injection
Sanofi-Aventis U.S. LLC
Injection
Rifampin Injection
Mylan Institutional, a Viatris Company
Injection
Rifampin Injection
Fresenius Kabi USA, LLC
Injection
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule